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NECLEOCEPTIN™
Novel Polynucleotide Vaccine for an Effective Fertility Control in Animals
A new mode of fertility control, Immunocontraceptlon has been adopted as
tool to solve the problem of overpopulation. Immunocontraception can be
achieved by vaccinating animals with gamete proteins or reproductive hor-
mones. The former are tissue specific; which means, other tissues will not be affected
after treatment, therefore Is of preference. One of the most useful gamete antigens is
zona pellucida (ZP) protein, an extracellular matrix covering the mammalian oocytes. It
composes of three sulphated glycoproteins, ZP1, ZP2 and ZP3, mediating sperm contact with the oocyte.
Given the fact that the availability of intact ZP3 is always limited and purified natural protein is less stable
compared to nucleic acid, polynucleotide
vaccination will be an excellent alterna-
tive.
NUCLEOCEPTIN™ a polynucleotide vac-
cine has been developed by our group
that carries the gene that encodes ZP3
protein for direct injection to animal. The
anti-fertility vaccine constructed is com-
prised of a mammalian expression vector
containing gene sequence encoding ZP3
protein.
Novel Polynucleotide Vaccine Nucleoceptint»
Administration of this vaccine facilitates in vivo expression of ZP3 protein,
which in turn stimulates the development of specific cellular and humoral
immune responses directed against the destruction of self-ZP3 protein of
oocytes. Animals Immunised with NUCLEOCEPTIN™ were infertile. The
reduction in average litter size of at least 90% is due to assured preven-
tion of follicle development. Ovaries of animals treated with
NUCLEOCEPTIN™showed direct prevention of mature follicles formation.
Excessive depletion of the functional follicles was accompanied by an in-
crease in the number of oocyte-free cell clusters. The ovaries became
atrophic and eventually ended up with premature ovarian dysfunction and
sterility. Alterations in ovarian function were also evidenced when the
Immunosterilised animals no longer sensitive to intensive exogenous hor-
monal (hCG) stimulation .. None of the treated animals showed sign of
recovery over extended period.
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The NUClEOCEPTIN™ has been proven as an excellent irreversible contraceptive vaccine. Its application
in fertility control is assured. The application is only via a simple injection. Expensive and complicated
invasive procedures like surgery and castration can now be avoided.
NUClEOCEPTINTI"is a patent pending PI20020030 invention.
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